UBS Group AG - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$2,448
-73.2%
5,079
-80.5%
0.00%
Q2 2023$9,146
-34.7%
25,983
+238.2%
0.00%
Q2 2022$14,000
+180.0%
7,682
+47.6%
0.00%
Q4 2021$5,000
-54.5%
5,205
+99.5%
0.00%
Q2 2021$11,000
-73.2%
2,609
-67.5%
0.00%
Q1 2021$41,000
+10.8%
8,039
+36.9%
0.00%
Q4 2020$37,000
+1750.0%
5,872
+991.4%
0.00%
Q3 2020$2,000
-99.8%
538
-99.7%
0.00%
Q2 2020$944,000
+23500.0%
160,665
+14694.2%
0.00%
Q1 2020$4,000
-84.6%
1,086
-71.6%
0.00%
Q4 2019$26,000
+225.0%
3,826
+121.4%
0.00%
Q3 2019$8,000
+700.0%
1,728
+1415.8%
0.00%
Q2 2019$1,000
-95.0%
114
-95.4%
0.00%
Q1 2019$20,000
-74.4%
2,483
-74.8%
0.00%
Q4 2018$78,000
-15.2%
9,837
+15.1%
0.00%
Q3 2018$92,000
+17.9%
8,546
+27.9%
0.00%
Q2 2018$78,000
+129.4%
6,684
+413.4%
0.00%
Q1 2018$34,000
-89.9%
1,302
-94.7%
0.00%
Q4 2017$338,000
+174.8%
24,747
+1.7%
0.00%
Q3 2017$123,000
+0.8%
24,345
-7.0%
0.00%
Q2 2017$122,000
-47.0%
26,169
+7.5%
0.00%
Q1 2017$230,00024,3450.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q3 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 66,951$13,8590.01%
Colorado Capital Management, Inc. 34,165$70.01%
Nantahala Capital Management 160,430$33,2090.00%
Kynam Capital Management, LP 89,886$18,6060.00%
Keebeck Wealth Management, LLC 20,000$4,1400.00%
MORGAN STANLEY 38,404$7,9500.00%
ACADIAN ASSET MANAGEMENT LLC 259,467$520.00%
BlackRock Inc. 169,904$35,1700.00%
Bank of New York Mellon Corp 200,638$41,5320.00%
Citadel Advisors 5,700$1,1800.00%
View complete list of CATALYST BIOSCIENCES INC shareholders